litlas
ログインアカウント作成

Robert S. Negrin

1989–2025 年に発表

134
論文数
22,425
被引用数
85
h 指数
131
i10 指数

被引用数

Robert S. Negrin の年別被引用数1948 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 2 件1994 年: 被引用 5 件1995 年: 被引用 12 件1996 年: 被引用 17 件1997 年: 被引用 19 件1998 年: 被引用 30 件1999 年: 被引用 30 件2000 年: 被引用 50 件2001 年: 被引用 109 件2002 年: 被引用 163 件2003 年: 被引用 169 件2004 年: 被引用 141 件2005 年: 被引用 199 件2006 年: 被引用 222 件2007 年: 被引用 236 件2008 年: 被引用 230 件2009 年: 被引用 215 件2010 年: 被引用 192 件2011 年: 被引用 188 件2012 年: 被引用 201 件2013 年: 被引用 172 件2014 年: 被引用 182 件2015 年: 被引用 144 件2016 年: 被引用 141 件2017 年: 被引用 133 件2018 年: 被引用 117 件2019 年: 被引用 455 件2020 年: 被引用 454 件2021 年: 被引用 546 件2022 年: 被引用 493 件2023 年: 被引用 382 件2024 年: 被引用 593 件2025 年: 被引用 286 件2026 年: 被引用 11 件1949〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,578 件、この内訳の 35.4%中国: 引用元論文 638 件、この内訳の 8.8%ドイツ: 引用元論文 576 件、この内訳の 7.9%イギリス: 引用元論文 389 件、この内訳の 5.4%イタリア: 引用元論文 349 件、この内訳の 4.8%フランス: 引用元論文 311 件、この内訳の 4.3%カナダ: 引用元論文 210 件、この内訳の 2.9%スペイン: 引用元論文 178 件、この内訳の 2.4%オーストラリア: 引用元論文 176 件、この内訳の 2.4%オランダ: 引用元論文 175 件、この内訳の 2.4%スイス: 引用元論文 166 件、この内訳の 2.3%日本: 引用元論文 162 件、この内訳の 2.2%
0%35.4%その他 18.8%

機関

分野

  • Medicine58.9%
  • Immunology and Microbiology25.5%
  • Biochemistry, Genetics and Molecular Biology12.8%
  • Engineering1.1%
  • Materials Science0.4%
  • Neuroscience0.4%
  • その他0.9%

トピック

  • Immune Cell Function and Interaction11.8%
  • CAR-T cell therapy research9.3%
  • Hematopoietic Stem Cell Transplantation8.3%
  • T-cell and B-cell Immunology8.2%
  • Immunotherapy and Immune Responses3.8%
  • Virus-based gene therapy research2.6%
  • その他56%

共著者

全論文

検索で開く
  1. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

    著者: Jay Y. Spiegel, Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird, Matthew J. Frank, Parveen Shiraz, Bita Sahaf, Juliana Craig, María Iglesias, Sheren Younes, Yasodha Natkunam, Michael G. Ozawa, Eric Yang, John Tamaresis, Harshini Chinnasamy, Zachary Ehlinger, Warren D. Reynolds, Rachel C. Lynn, Maria Caterina Rotiroti, Nikolaos Gkitsas, Sally Arai, Laura Johnston, Robert Lowsky, Robbie G. Majzner, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Judith A. Shizuru, Wen‐Kai Weng, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Magali Bazzano, Jing Zhou, Sean Mackay, Scott J. Bornheimer, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Katherine A. Kong, Nirali N. Shah, Haiying Qin, Terry J. Fry, Steven A. Feldman, Crystal L. Mackall, David B. Miklos - Nature Medicine 2021 被引用: 572

  2. Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

    著者: John H. Baird, David J. Epstein, John Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, J. Martin Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen‐Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana - Blood Advances 2021 被引用: 193

  3. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

    著者: Janelle A. Olson, Dennis B. Leveson-Gower, Saar Gill, Jeanette Baker, Andreas Beilhack, Robert S. Negrin - Blood 2010 被引用: 376

  4. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

    著者: Matthias Edinger, Petra Hoffmann, Joerg Ermann, Kathryn Drago, C. Garrison Fathman, Samuel Strober, Robert S. Negrin - Nature Medicine 2003 被引用: 1,281

  5. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    著者: Robert Zeiser, Andreas Burchert, Claudia Lengerke, Mareike Verbeek, Kristina Maas‐Bauer, Stephan Metzelder, Silvia Spoerl, Markus Ditschkowski, Matyas Ecsedi, Katja Sockel, Francis Ayuk, Salem Ajib, Flore Sicre de Fontbrune, Il‐Kang Na, Livius Penter, Udo Holtick, Dominik Wolf‎, Esther Schuler, Everett Meyer, Petya Apostolova, Hartmut Bertz, Reinhard Marks, Michael Lübbert, Ralph Wäsch, Christof Scheid, Friedrich Stölzel, Rainer Ordemann, Gesine Bug, Guido Kobbe, Robert S. Negrin, Mats Brune, Alexandros Spyridonidis, A Schmitt-Gräff, Walter J. F. M. van der Velden, Gerwin Huls, Stephan Mielke, Goetz Ulrich Grigoleit, Jürgen Kuball, Ryan Flynn, Gabriele Ihorst, Jing Du, Bruce R. Blazar, R. Arnold, Nicolaus Kröger, Jakob Passweg, Jörg Halter, G. Socié, Dietrich W. Beelen, Christian Peschel, Andreas Neubauer, Jürgen Finke, Justus Duyster, Nikolas von Bubnoff - Leukemia 2015 被引用: 540

  6. Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation

    著者: Loredana Ruggeri, Marusca Capanni, Myriam Casucci, Isabella Volpi, Antonellá Tosti, Katia Perruccio, Elena Urbani, Robert S. Negrin, Massimo F. Martelli, Andrea Velardi - Blood 1999 被引用: 991

  7. Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation

    著者: Federico Simonetta, Maite Álvarez, Robert S. Negrin - Frontiers in Immunology 2017 被引用: 196

  8. T cells expressing chimeric antigen receptor promote immune tolerance

    著者: Antonio Pierini, Bettina P. Iliopoulou, Heshan Peiris, Magdiel Pérez-Cruz, Jeanette Baker, Katie Hsu, Xueying Gu, Pingping Zheng, Tom Erkers, Sai-Wen Tang, W Strober, Maite Álvarez, Aaron M. Ring, Andrea Velardi, Robert S. Negrin, Seung K. Kim, Everett Meyer - JCI Insight 2017 被引用: 105

  9. Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

    著者: Andrew Johnsrud, Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder, John Tamaresis, Robert S. Negrin, Laura Johnston, Sally Arai, Judith A. Shizuru, Robert Lowsky, Everett Meyer, Wen‐Kai Weng, Parveen Shiraz, Andrew R. Rezvani, Theresa Latchford, Crystal L. Mackall, David B. Miklos, Matthew J. Frank, Surbhi Sidana - Blood Advances 2021 被引用: 77

  10. Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells

    著者: Lior Zangi, Raanan Margalit, Shlomit Reich-Zeliger, Esther Bachar-Lustig, Andreas Beilhack, Robert S. Negrin, Yaīr Reisner - Stem Cells 2009 被引用: 292

  11. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells

    著者: Saar Gill, Adrianne E Vasey, Alysha De Souza, Jeanette Baker, Aaron T. Smith, Holbrook E. Kohrt, Mareike Florek, Kenneth D. Gibbs, Keri Tate, David S. Ritchie, Robert S. Negrin - Blood 2012 被引用: 169

  12. Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming

    著者: Federico Simonetta, Juliane K. Lohmeyer, Toshihito Hirai, Kristina Maas‐Bauer, Maite Álvarez, Arielle S. Wenokur, Jeanette Baker, Amin Aalipour, Xuhuai Ji, Samuel Haile, Crystal L. Mackall, Robert S. Negrin - Clinical Cancer Research 2021 被引用: 56

  13. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway

    著者: Maite Álvarez, Federico Simonetta, Jeanette Baker, Antonio Pierini, Arielle S. Wenokur, Alyssa R. Morrison, William J. Murphy, Robert S. Negrin - JCI Insight 2019 被引用: 94

  14. MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors

    著者: Dominik Marschner, Martina Falk, Nóra Rebeka Jávorniczky, Kathrin Hanke-Müller, Justyna Rawluk, Annette Schmitt‐Graeff, Federico Simonetta, Eileen Haring, Severin Dicks, Manching Ku, Sandra Duquesne, Konrad Aumann, David Rafei‐Shamsabadi, Frank Meiß, Patrick S. Marschner, Melanie Boerries, Robert S. Negrin, Justus Duyster, Robert Zeiser, Natalie Köhler - JCI Insight 2020 被引用: 87

  15. CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

    著者: Matthew J. Frank, John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown, Jean Oak, Sheren Younes, Yasodha Natkunam, Mark Hamilton, Yi‐Jiun Su, Neha Agarwal, Harshini Chinnasamy, Emily Egeler, Sharon Mavroukakis, Steven A. Feldman, Bita Sahaf, Crystal L. Mackall, Lori Muffly, David B. Miklos, Dorota D. Klysz, Nikolaos Gkitsas-Long, Juliana Bacigalupi, María Iglesias, Emma Crawford, Linnea Nichols, Kristen Cunanan, John Tamaresis, Jay Y. Spiegel, Zachary Ehlinger, Adam Kuo, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen Kai Weng, Sushma Bharadwaj, Saurabh Dahiya, Melody Smith, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Ramya Tunuguntla - The Lancet 2024 被引用: 57

  16. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

    著者: Michael R. Verneris, Mobin Karami, Jeanette Baker, Anishka Jayaswal, Robert S. Negrin - Blood 2003 被引用: 379

  17. CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

    著者: John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean Oak, Sheren Younes, Michael G. Ozawa, Eric Yang, Yasodha Natkunam, John Tamaresis, Zachary Ehlinger, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen‐Kai Weng, Kara L. Davis, Sneha Ramakrishna, Liora M. Schultz, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Lori Muffly - Blood 2020 被引用: 80

  18. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

    著者: Ryosei Nishimura, Jeanette Baker, Andreas Beilhack, Robert Zeiser, Janelle A. Olson, Emanuela Sega, Mobin Karimi, Robert S. Negrin - Blood 2008 被引用: 199

  19. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant

    著者: John A. Ronald, Byung-Su Kim, Gayatri Gowrishankar, Mohammad Namavari, Israt S. Alam, Aloma D’Souza, Hidekazu Nishikii, Hui-Yen Chuang, Ohad Ilovich, Chih-Feng Lin, Robert E. Reeves, Adam J. Shuhendler, Aileen Hoehne, Carmel T. Chan, Jeanette Baker, Shahriar Yaghoubi, Henry F. VanBrocklin, Randall A. Hawkins, Benjamin L. Franc, Salma Jivan, James B. Slater, Emily F. Verdin, Kenneth T. Gao, Jonathan Benjamin, Robert S. Negrin, Sanjiv S. Gambhir - Cancer Research 2017 被引用: 133

  20. Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients

    著者: Everett Meyer, Ginna G. Laport, Bryan J. Xie, Kate MacDonald, Kartoosh Heydari, Bita Sahaf, Sai-Wen Tang, Jeanette Baker, Randall Armstrong, Keri Tate, Cynthia Tadisco, Sally Arai, Laura Johnston, Robert Lowsky, Lori Muffly, Andrew R. Rezvani, Judith A. Shizuru, Wen‐Kai Weng, Kevin Sheehan, David B. Miklos, Robert S. Negrin - JCI Insight 2019 被引用: 82

  21. Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

    著者: Sergio Giralt, Luciano J. Costa, Jeffrey Schriber, John F. DiPersio, Richard T. Maziarz, John M. McCarty, Paul Shaughnessy, Edward L. Snyder, William Bensinger, Edward A. Copelan, Chitra Hosing, Robert S. Negrin, Finn Bo Petersen, Damiano Rondelli, Robert J. Soiffer, Helen Leather, Amy Pazzalia, Steven M. Devine - Biology of Blood and Marrow Transplantation 2013 被引用: 404

  22. CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results

    著者: Liora M. Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, Bita Sahaf, Hrishi Srinagesh, Parveen Shiraz, Neha Agarwal, Mark Hamilton, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott, Sally Arai, Sushma Bharadwaj, Laura Johnston, Michaela Liedtke, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, JUDY A. SHIZURU, Surbhi Sidana, Emily Egeler, Sharon Mavroukakis, Ramya Tunuguntla, Nikolaos Gkitsas-Long, Aidan Retherford, Annie Kathleen Brown, Anne-Louise Gramstrap-Petersen, Raquel Martin Ibañez, Steven A. Feldman, David B. Miklos, Crystal L. Mackall, Kara L. Davis, Matthew J. Frank, Sneha Ramakrishna, Lori Muffly - Leukemia 2024 被引用: 40

  23. CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

    著者: Mark Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani, Zachary Ehlinger, Shriya Syal, Zinaida Good, Brian J. Sworder, Joseph G. Schroers‐Martin, Ying Lü, Lori Muffly, Robert S. Negrin, Sally Arai, Robert Lowsky, Everett Meyer, Andrew R. Rezvani, Judith A. Shizuru, Wen‐Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, David M. Kurtz, Crystal L. Mackall, Robert Tibshirani, Ash A. Alizadeh, Matthew J. Frank, David B. Miklos - Blood Advances 2024 被引用: 24

  24. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

    著者: Robert Zeiser, Vu Nguyen, Andreas Beilhack, Martin Buess, Stephan Schulz, Jeanette Baker, Christopher H. Contag, Robert S. Negrin - Blood 2006 被引用: 498